p53 TAD(50-54) Ala-substituted peptide
General Information
DRACP ID DRACP01174
Peptide Name p53 TAD(50-54) Ala-substituted peptide
Sequence AEQAA
Sequence Length 5
UniProt ID Not available
PubChem CID Not available
Origin p57 protein
Type Native peptide
Classification
Active ACP Cancer targeted peptides
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | When the peptide concentrations were 1 μM, 10 μM, 100 μM, 300μM, the Cell viability(%) was 90%, 95%, 81%, 79% | MTT assay | 24 h | Patent |
HCT 116 | Colon carcinoma | Carcinoma | When the peptide concentrations were 1 μM, 10 μM, 100 μM, 300μM, the Cell viability(%) was 95%, 89%, 82%, 70% | MTT assay | 24 h | Patent |
A549 | Lung adenocarcinoma | Carcinoma | When the peptide concentrations were 1 μM, 10 μM, 100 μM, 300μM, the Cell viability(%) was 100%, 100%, 90%, 82% | MTT assay | 24 h | Patent |
SNU-719 | Gastric tubular adenocarcinoma | Carcinoma | When the peptide concentrations were 1 μM, 10 μM, 100 μM, 300μM, the Cell viability(%) was 92%, 90%, 82%, 80% | MTT assay | 24 h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target mdm2 (mouse double minute 2)
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C19H32N6O9
Absent amino acids CDFGHIKLMNPRSTVWY
Common amino acids A
Mass 56004
Pl 3.85
Basic residues 0
Acidic residues 1
Hydrophobic residues 3
Net charge -1
Boman Index -692
Hydrophobicity -32
Aliphatic Index 60
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID KR20050098766A
Patent Title Peptides for Inhibiting Mdm2 Function
Other Iinformation Patent Application; Family: 5s / 5ex; Family Jurisdictions: KR, US, WO; Legal Status: Inactive; Application No: 20050000931; Filed: Jan 5, 2005; Published: Oct 12, 2005; Earliest Priority: Apr 6, 2004; Granted: Dec 27, 2007
Other Published ID KR100788928B1 US2009030181A1 US8598127B2 WO2005097820A1